From road rage compilations to single shocking clips, the pattern is remarkably consistent: an impatient driver crowds the ...

This video features Touristenfahrten sessions at the Nürburgring Nordschleife, highlighting dangerous driving behavior, ...

The actress “couldn’t control” her bowels after taking a weight-loss drug and admitted to relieving herself backstage after ...

We may receive a commission on purchases made from links. The concept of a battery is not a new one, and it may in fact date back more than a couple thousand years. However, it was a French physicist ...

PITTSBURGH – Dylan Larkin is headed to the Olympics. The Red Wings’ captain, and Waterford native and former Michigan star, was officially named by USA Hockey Friday for its Olympic men’s team during ...

Love Island USA isn’t a new show. The dating reality show debuted in 2019, after a stint on CBS, and moved to Peacock in 2022. It has been a steady series with a devoted audience since then, but it ...

The National Highway Traffic Safety Administration issued multiple recalls for vehicles last week, including notices for over 55,000 Toyota vehicles. Are you looking to see if recalls have been issued ...

Delivery fails involving 10-year Treasury notes surged to the highest level in eight years this month, a result of the Federal Reserve’s move to shrink its bond portfolio since 2022. Trades involving ...

As snow and cold weather return to New Jersey, state officials are reminding drivers that all snow and ice must be cleared from vehicles before heading out on the road or they could face fines. Under ...

New York Yankees captain Aaron Judge has signed on to play for Team USA in the 2026 World Baseball Classic, and he is already getting some reps in for the March games. On a recent Instagram story, ...

Turning Point USA (TPUSA) leaders publicly confirmed their support for Vice President JD Vance during AmericaFest, saying the endorsement reflects longtime ties between Vance and the late Charlie Kirk ...

Compared with placebo, secukinumab — an interleukin-17A inhibitor — did not show greater clinical efficacy in treating moderate-to-severe Graves' orbitopathy (GO); however, the drug was well tolerated ...